Want to join the conversation?
$ESV 2Q15 Call: In a mutually negotiated deal. We extended the contract term for ENSCO DS-7 in Angola to the fourth quarter of 2017. Gaining approximately $125MM of revenue backlog on a net basis since as part of this agreement the DS-1 was terminated early, as a result we have accelerated our plans to cold stack DS-1.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?